Castroagudín, Javier F <br/><br/>
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.  [electronic resource] 

 -  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society  Dec 2009 
 - 1792-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1527-6473 
<br/><br/><label>Standard No.: </label>10.1002/lt.21920  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Calcineurin Inhibitors<br/>Chronic Disease<br/>Creatinine--blood<br/>Cyclosporine--administration & dosage<br/>Drug Administration Schedule<br/>Everolimus<br/>Feasibility Studies<br/>Female<br/>Glomerular Filtration Rate--drug effects<br/>Graft Rejection--etiology<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Diseases--etiology<br/>Liver Diseases--surgery<br/>Liver Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Sirolimus--administration & dosage<br/>Tacrolimus--administration & dosage<br/>Time Factors<br/>Treatment Outcome